Aromatase gene polymorphisms are associated with survival among patients with cardiovascular disease in a sex-specific manner

PLoS ONE

Volumn 5, Issue 12, 2010, Pages 1-6

  Beitelshees, Amber L ^a   Johnson, Julie A ^b   Hames, Megan L ^b   Gong, Yan ^b   Cooper Dehoff, Rhonda M ^b   Wu, Jun ^c   Cresci, Sharon ^c   Ma, Cynthia X ^c   Pepine, Carl J ^d   Province, Michael A ^c   Spertus, John A ^e   McLeod, Howard L ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; AROMATASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST;

ACUTE CORONARY SYNDROME; ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HAZARD RATIO; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; UNSTABLE ANGINA PECTORIS; CASE CONTROL STUDY; COHORT ANALYSIS; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; AGED; AROMATASE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS; TREATMENT OUTCOME;

EID: 78650739680     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015180     Document Type: Article

References (18)

1. Peter I, Shearman AM, Zucker DR, Schmid CH, Demissie S, et al. (2005) Variation in estrogen-related genes and cross-sectional and longitudinal blood pressure in the Framingham Heart Study. J Hypertens 23: 2193-2200.
2. Ramirez-Lorca R, Grilo A, Martinez-Larrad MT, Manzano L, Serrano- Hernando FJ, et al. (2007) Sex and body mass index specific regulation of blood pressure by CYP19A1 gene variants. Hypertension 50: 884-890.
3. Ren J, Kelley RO (2009) Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology. Obesity (Silver Spring) 17: 1114-1123.
4. Vitale C, Mendelsohn ME, Rosano GM (2009) Gender differences in the cardiovascular effect of sex hormones. Nat Rev Cardiol 6: 532-542.
5. Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, et al. (2005) Beta2- adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome. Jama 294: 1526-1533.
6. Braunwald E (1989) Unstable angina. A classification. Circulation 80: 410-414.
7. Beitelshees AL, Gong Y, Wang D, Schork NJ, Cooper-Dehoff RM, et al. (2007) KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST). Pharmacogenet Genomics 17: 719-729.
8. Pacanowski MA, Gong Y, Cooper-Dehoff RM, Schork NJ, Shriver MD, et al. (2008) beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension. Clin Pharmacol Ther 84: 715-721.
9. Ma CX, Adjei AA, Salavaggione OE, Coronel J, Pelleymounter L, et al. (2005) Human aromatase: gene resequencing and functional genomics. Cancer Res 65: 11071-11082.
10. Mehilli J, Kastrati A, Dirschinger J, Bollwein H, Neumann FJ, et al. (2000) Differences in prognostic factors and outcomes between women and men undergoing coronary artery stenting. Jama 284: 1799-1805.
11. Radovanovic D, Erne P, Urban P, Bertel O, Rickli H, et al. (2007) Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry. Heart 93: 1369-1375.
12. Peter I, Kelley-Hedgepeth A, Fox CS, Cupples LA, Huggins GS, et al. (2008) Variation in estrogen-related genes associated with cardiovascular phenotypes and circulating estradiol, testosterone, and dehydroepiandrosterone sulfate levels. J Clin Endocrinol Metab 93: 2779-2785.
13. Ellegren H, Parsch J (2007) The evolution of sex-biased genes and sex-biased gene expression. Nat Rev Genet 8: 689-698.
14. Parisi M, Nuttall R, Naiman D, Bouffard G, Malley J, et al. (2003) Paucity of genes on the Drosophila X chromosome showing male-biased expression. Science 299: 697-700.
15. Ranz JM, Castillo-Davis CI, Meiklejohn CD, Hartl DL (2003) Sex-dependent gene expression and evolution of the Drosophila transcriptome. Science 300: 1742-1745.
16. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, et al. (2008) Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 93: 1276-1284.
17. Ding EL, Song Y, Malik VS, Liu S (2006) Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. Jama 295: 1288-1299.
18. Khaw KT, Dowsett M, Folkerd E, Bingham S, Wareham N, et al. (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 116: 2694-2701.